After acknowledging the potential role of the neutral amino acid transporters addressed here on the hallmarks of cancer, the focus of researchers and pharmaceuticals on ASCT2 and LAT1 clinical relevance is to be expected [130] (Figure 5). This evidence concerns the gene SLC7A5 and cancer.